Skip to main content
Year archive

AstraZeneca PLC — 2026 filings

All 85 regulatory filings released by AstraZeneca PLC (AZN) in 2026, sourced directly from the official regulator.

85 Filings
2026 Period
2026 filings (85)
Filing Released Lang
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Foreign Filer Report
2026-05-01 English
Total Voting Rights and Admission of Shares
Declaration of Voting Results & Voting Rights Announcements
2026-05-01 English
Total Voting Rights and Admission of Shares
Regulatory Filings
2026-05-01 English
FDA ODAC vote on camizestrant in breast cancer
Regulatory Filings
2026-05-01 English
FDA ODAC recommends Truqap in prostate cancer
Regulatory Filings
2026-05-01 English
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Foreign Filer Report
2026-04-29 English
1st Quarter Results
Earnings Release Q1 2026
2026-04-29 English
Interim / Quarterly Report 2026
Interim / Quarterly Report Q1 2026
2026-04-29 English
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Foreign Filer Report
2026-04-28 English
Breztri approved in the US for asthma
Regulatory Filings
2026-04-28 English
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Foreign Filer Report
2026-04-27 English
Saphnelo self-administration approved in the US
Regulatory Filings
2026-04-27 English
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Foreign Filer Report
2026-04-23 English
Directorate change
Board/Management Information
2026-04-23 English
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Foreign Filer Report
2026-04-21 English
I CAN PhIII interim analysis met primary endpoint
Regulatory Filings
2026-04-21 English
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Foreign Filer Report
2026-04-20 English
Third tozorakimab positive Phase III in COPD
Regulatory Filings
2026-04-20 English
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Foreign Filer Report
2026-04-09 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2026-04-09 English
Special Business Approved at AGM
AGM Information
2026-04-09 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2026-04-09 English
25-NSE - ASTRAZENECA PLC (0000901832) (Subject)
Delisting Announcement
2026-04-08 English
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Foreign Filer Report
2026-04-02 English
Imfinzi+Imjudo improves PFS in early liver cancer
Regulatory Filings
2026-04-02 English
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Foreign Filer Report
2026-04-01 English
Total Voting Rights and Admission of Shares
Share Issue/Capital Change
2026-04-01 English
Total Voting Rights and Admission of Shares
Share Issue/Capital Change
2026-04-01 English
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Foreign Filer Report
2026-03-31 English
Efzimfotase alfa Ph3 program show positive results
Regulatory Filings
2026-03-31 English
Efzimfotase alfa Ph3 program show positive results
Regulatory Filings
2026-03-31 English
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Foreign Filer Report
2026-03-27 English
Tozorakimab met OBERON/TITANIA primary endpoints
Regulatory Filings
2026-03-27 English
Tozorakimab met OBERON/TITANIA primary endpoints
Regulatory Filings
2026-03-27 English
6-K - ASTRAZENECA PLC (0000901832) (Filer)
Foreign Filer Report
2026-03-20 English
Notification of Admission of Shares
Share Issue/Capital Change
2026-03-20 English
3 - ASTRAZENECA PLC (0000901832) (Issuer)
Director's Dealing
2026-03-20 English
Imfinzi approved in EU for early gastric cancer
Regulatory Filings
2026-03-16 English
Notice of AGM
Report Publication Announcement
2026-03-10 English
PSP share plan rules - for shareholder approval at 2026 AGM
Remuneration Information
2026-03-10 English
Notice of AGM
Report Publication Announcement
2026-03-10 English
Proxy Form for 2026 AGM
Proxy Solicitation & Information Statement
2026-03-10 English
Notice of AGM
Proxy Solicitation & Information Statement
2026-03-10 English
Director/PDMR Shareholding
Director's Dealing
2026-03-06 English
Director/PDMR Shareholding
Director's Dealing
2026-03-06 English
Director/PDMR Shareholding
Director's Dealing
2026-03-06 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements
2026-03-02 English
AstraZeneca prices a $2bn bond offering
Capital/Financing Update
2026-02-26 English
AstraZeneca prices a $2bn bond offering
Capital/Financing Update
2026-02-26 English
Filing of Form 20-F with SEC
Report Publication Announcement
2026-02-25 English
20-F - ASTRAZENECA PLC (0000901832) (Filer)
Annual Report FY 2025
2026-02-24 English
Annual Financial Report
Annual Report
2026-02-24 English
Annual Financial Report
Report Publication Announcement
2026-02-24 English
Annual Report (ESEF) 2025
Annual Report (ESEF) FY 2025
2026-02-24 English
2025 Annul Report & 20-F Information
Annual Report (ESEF)
2026-02-24 English
2025 Annul Report & 20-F Information
Annual Report
2026-02-24 English
Directorate change
Board/Management Information
2026-02-24 English
Directorate Change
Board/Management Information
2026-02-24 English
Fixed-duration Calquence combo approved in US
Regulatory Filings
2026-02-20 English
Final Results
Regulatory Filings
2026-02-10 English
Earnings Release 2025
Earnings Release Q4 2025
2026-02-10 English
6-K Filing
Foreign Filer Report
2026-02-10 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-06 English
SCHEDULE 13D/A Filing
Major Shareholding Notification
2026-02-06 English
Update on Saphnelo subcutaneous administration
Regulatory Filings
2026-02-03 English
6-K Filing
Foreign Filer Report
2026-02-03 English
Total Voting Rights
Regulatory Filings
2026-02-02 English
Total Voting Rights
Regulatory Filings
2026-02-02 English
Imfinzi recommended in EU for early gastric cancer
Regulatory Filings
2026-02-02 English
AstraZeneca begins trading on NYSE
Regulatory Filings
2026-02-02 English
S-8 Filing
Registration Form
2026-02-02 English
6-K Filing
Foreign Filer Report
2026-02-02 English
6-K Filing
Foreign Filer Report
2026-02-02 English
6-K Filing
Foreign Filer Report
2026-02-02 English
AstraZeneca agrees obesity and T2D deal with CSPC
Regulatory Filings
2026-01-30 English
6-K Filing
Foreign Filer Report
2026-01-30 English
25 Filing
Delisting Announcement
2026-01-30 English
AstraZeneca invests $15bn in China through 2030
Regulatory Filings
2026-01-29 English
6-K Filing
Foreign Filer Report
2026-01-29 English
AstraZeneca to complete direct listing on NYSE
Regulatory Filings
2026-01-20 English
6-K Filing
Foreign Filer Report
2026-01-20 English
AZN new Head of Investor Relations Joris Silon
Board/Management Information
2026-01-08 English
Total Voting Rights
Regulatory Filings
2026-01-02 English
Total Voting Rights
Regulatory Filings
2026-01-02 English
6-K Filing
Foreign Filer Report
2026-01-02 English